[Therapy of toxoplasmosis].
D006801:Humans; D011719:Pyrazines / Q000009:adverse effects / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*; D014123:Toxoplasmosis / Q000188:drug therapy*
D011719:Pyrazines; D013449:Sulfonamides
Tratamiento de la toxoplasmosis.